Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience

被引：0
|
作者：
Ghamsari, Farid [1 ]
Trando, Aaron [2 ]
Medley, Katherine [3 ]
Martino, Janine [3 ]
Block, Shanna [3 ]
Wells, Kaitlyn [3 ]
Doan, Thu [3 ]
Quach, Anthony [3 ]
Cheng, Renee [4 ]
Costello, Caitlin [1 ]
Jeong, Autumn [5 ]
Saunders, Ila [6 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] UCSD Sch Med, San Diego, CA USA
[3] UCSD Hlth, Dept Pharm, San Diego, CA USA
[4] UCSD Hematol Oncol Fellowship Program, San Diego, CA USA
[5] UCSD Div Blood & Bone Marrow Transplantat, San Diego, CA USA
[6] UCSD Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-025
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [21] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Single Center Experience
    Hultcrantz, Malin
    Derkach, Andriy
    Hassoun, Hani
    Korde, Neha
    Maclachlan, Kylee H.
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Akhlaghi, Theresia
    Hamadeh, Issam S.
    Chung, David J.
    Lahoud, Oscar B.
    Landau, Heather
    Scordo, Michael
    Shah, Gunjan L.
    Giralt, Sergio A.
    Lesokhin, Alexander M.
    Usmani, Saad
    BLOOD, 2022, 140 : 7246 - 7248
  • [22] Clinical Outcomes of Teclistamab among MajesTEC-1 Eligible and Ineligible Population in the Real-World Setting for the Treatment of Relapsed/Refractory Multiple Myeloma
    Tan, Carlyn
    Derkach, Andriy
    Maclachlan, Kylee
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi
    Rajeeve, Sridevi
    Hashmi, Hamza
    Shah, Gunjan
    Scordo, Michael
    Chung, David
    Landau, Heather
    Giralt, Sergio
    Lesokhin, Alexander
    Korde, Neha
    Lin, Dee
    Wu, Bingcao
    Fowler, Jessica
    Fernandez, Mariana
    Kim, Nina
    Doyle, Margaret
    Hester, Laura
    Orozco, Jennifer
    Usmani, Saad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S91 - S92
  • [23] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [24] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [25] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Real-World Outcomes for the Treatment of Relapsed/Refractory Multiple Myeloma With Daratumumab: A Systematic Literature Review
    Gros Otero, B.
    Gungor, G.
    Gruppe, T. L.
    Wan, M.
    Jenkins, C.
    Helme, K.
    VALUE IN HEALTH, 2022, 25 (12) : S494 - S494
  • [27] Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group
    Ntanasis-Stathopoulos, Ioannis
    Katodrytou, Eirini
    Hatjiharissi, Evdoxia
    Spanoudakis, Emmanouil
    Douka, Vasiliki
    Fotiou, Despina
    Labropoulou, Vasiliki
    Dalampira, Dimitra
    Spiliopoulou, Vasiliki
    Papadopoulou, Theodosia
    Christoulas, Dimitrios
    Malandrakis, Panagiotis
    Bouchla, Anthi
    Pappa, Vasiliki
    Kastritis, Efstathios
    Terpos, Evangelos
    Dimopoulos, Meletios
    Gavriatopoulou, Maria
    BLOOD, 2024, 144 : 6988 - 6990
  • [28] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
    Hultcrantz, Malin
    Orozco, Jennifer
    Peterson, Tim J.
    Derkach, Andriy
    Hassoun, Hani
    Korde, Neha
    Lu, Sydney X.
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Maclachlan, Kylee H.
    Chung, David J.
    Landau, Heather J.
    Shah, Gunjan L.
    Lahoud, Oscar B.
    Scordo, Michael
    Landgren, Ola
    Giralt, Sergio
    Lesokhin, Alexander
    BLOOD, 2021, 138
  • [29] Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience
    Khan, Abdullah M.
    Ozga, Michael
    Bhatt, Harshil
    Faisal, Muhammad S.
    Ansari, Sadia
    Zhao, Qiuhong
    Bumma, Naresh
    Cottini, Francesca
    Devarakonda, Srinivas
    Rosko, Ashley
    Sharma, Nidhi
    Umyarova, Elvira
    Benson, Don
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (03): : E182 - E189
  • [30] Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience
    Ghafouri, Sanaz
    Fenerty, Kathleen
    Schiller, Gary
    de Vos, Sven
    Eradat, Herbert
    Timmerman, John
    Larson, Sarah
    Mead, Monica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12): : 861 - 872
12345